FONAR Corporation ( FONR ) NASDAQ Capital Market

Cena: 14.1 ( -0.53% )

Aktualizacja 06-23 21:16
NASDAQ Capital Market
Branża: Medical - Devices

Notowania:


Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Devices
Zatrudnienie: 520
Giełda: NASDAQ Capital Market
Ilość akcji w obrocie: 98%
Ilość akcji: 6 328 290
Debiut giełdowy: 1981-10-29
WWW: https://www.fonar.com
CEO: Mr. Timothy R. Damadian M.D.
Adres: 110 Marcus Drive
Siedziba: 11747 Melville
ISIN: US3444374058
Opis firmy:

Fonar Corporation, wraz z spółkami zależnymi, angażuje się w badania, rozwój, produkcję i marketing skanerów rezonansu magnetycznego (MRI) w celu wykrywania i rozpoznania chorób ludzkich w Stanach Zjednoczonych. Firma działa za pośrednictwem dwóch segmentów, segmentu sprzętu medycznego oraz segmentu zarządzania lekarzami i usług diagnostycznych. Zapewnia wyprostowany skaner MRI, który pozwala pacjentom skanować w warunkach obciążenia, takich jak stojący, siedzenie, zginanie lub leżenie. Firma oferuje zarządzanie niemedyczne, w tym usługi administracyjne, usługi rozliczeniowe i gromadzenia, usługi poświadczeń, negocjacje umowy, konsultacje w zakresie zgodności, zakupy IT, zatrudnienie, przeprowadzanie wywiadów, szkolenia, nadzoru i zarządzania strategiami wzrostu i wdrożenia i wdrażania pracowników nie-medycznych. Firma jest właścicielem i obsługą 5 placówek obrazowych diagnostycznych na Florydzie; i zarządza 39 obiektami skanowania MRI, w tym 25 obiektów położonych w Nowym Jorku i 14 położonych na Florydzie. Skanery sprzedaje swoje prywatne centra obrazowania diagnostycznego i szpitale. Firma została zarejestrowana w 1978 roku i ma siedzibę w Melville w Nowym Jorku.

Wskaźniki finansowe
Kapitalizacja (USD) 87 498 704
Aktywa: 212 290 000
Cena: 14.1
Wskaźnik Altman Z-Score: 2.5
Umiarkowany (ryzyko bankructwa średnie)
Dywidenda: 0
P/E: 11.3
Ilość akcji w obrocie: 98%
Średni wolumen: 23 275
Ilość akcji 6 203 470
Wskaźniki finansowe
Przychody TTM 102 007 089
Zobowiązania: 53 463 000
Przedział 52 tyg.: 12.0 - 18.68
Piotroski F-Score: 9
Silny (dobra jakość finansowa)
EPS: 1.2
P/E branży: 26.8
Beta: 1.194
Raport okresowy: 2025-05-15
WWW: https://www.fonar.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Ms. Claudette J. V. Chan Secretary & Director 58 880 1938
Mr. Luciano B. Bonanni Chief Operating Officer, Executive Vice President & Acting Principal Financial Officer 449 216 1955
Mr. Timothy R. Damadian M.D. Chairman, President, Chief Executive Officer & Treasurer 152 900 1964
Mr. Daniel Culver Director of Communications 0 0
Wiadomości dla FONAR Corporation
Tytuł Treść Źródło Aktualizacja Link
Fonar Announces Fiscal 2025 Financial Results for 3rd Quarter and Nine-Month Period Net Income increased 25% to $3.1 million for the quarter ended March 31, 2025 as compared to the quarter ended March 31, 2024. Income from Operations for the quarter ended March 31, 2025 decreased 2% to $3.7 million as compared to the quarter ended March 31, 2024. newsfilecorp.com 2025-05-15 11:00:00 Czytaj oryginał (ang.)
FONR Stock Declines After Q2 Earnings, Revenue and Net Income Fall FONAR's second-quarter fiscal 2025 revenues and net income decline. Higher costs and lower scan volumes weigh on results. zacks.com 2025-02-21 13:40:27 Czytaj oryginał (ang.)
Fonar Announces Six Month and 2nd Quarter Financial Results for Fiscal 2025 MRI scan volume at HMCA managed sites increased 7% to 79,207 scans during the six-month period ended December 31, 2024, versus 73,776 scans for the six-month period ended December 31, 2023. MRI scan volume at HMCA owned sites decreased 4% to 26,961 scans during the six-month period ended December 31, 2024, versus 28,214 scans for the six-month period ended December 31, 2023. newsfilecorp.com 2025-02-18 09:37:00 Czytaj oryginał (ang.)
FONAR: Assets Remain Too Cheap To Pass Up Despite recent underperformance, FONAR remains a value play with minimal debt, positive profitability, and attractive valuation multiples, particularly a P/B ratio of 0.61. Q1-Fiscal 2025 earnings showed a decline, but FONAR's book value continues to grow, driven by strategic investments in high-field MRI scanners and new locations. Risks include market punishment for near-term growth rates and low trading volume, but downside risk is limited due to strong financials and shareholder-friendly trends. seekingalpha.com 2024-12-04 16:15:17 Czytaj oryginał (ang.)
FONR Stock Gains Despite Q1 Earnings Dip and Rising Expenses FONAR's fiscal first-quarter earnings reveals a decline in revenues and income, driven by decreased patient fees and rising costs, while MRI scan volume sees modest growth. zacks.com 2024-11-13 15:26:13 Czytaj oryginał (ang.)
Fonar Announces Financial Results for the 1st Quarter of Fiscal 2025 Total MRI scan volume at the HMCA-managed sites increased 5% to 53,054 scans for the quarter ending September 30, 2024 versus the corresponding quarter one year earlier. Cash and cash equivalents decreased 4% to $54.2 million at September 30, 2024 as compared to the fiscal year-ended June 30, 2024. newsfilecorp.com 2024-11-12 09:00:00 Czytaj oryginał (ang.)
FONR's Stock Down Despite Earnings, Revenues Uptick in Fiscal 2024 Strength in FONAR's HMCA segment's revenues drives its top line in fiscal 2024. zacks.com 2024-09-30 17:36:27 Czytaj oryginał (ang.)
Fonar Announces Fiscal 2024 Financial Results Total MRI scan volume at the HMCA-managed sites increased 11% to 209,327 scans for the fiscal year ending June 30, 2024 as compared to the prior year. Cash and Cash Equivalents increased 10% to $56.3 million at June 30, 2024 versus the previous fiscal year. newsfilecorp.com 2024-09-27 20:24:00 Czytaj oryginał (ang.)
FONAR Corporation: Shares Look Ready To Embark On A Sustained Bullish Run (Technical Analysis) FONAR Corporation showed encouraging growth trends in revenues and earnings, leading to a 'Buy' rating last year. Recent technical trends suggest a potential long-term change in the stock trend, supported by strong near-term growth rates and a favorable valuation. Forward-looking fundamentals, including the adoption of SwiftMR, indicate potential for continued growth and profitability for FONR shareholders. seekingalpha.com 2024-07-16 05:29:06 Czytaj oryginał (ang.)
Zacks Initiates Coverage of FONAR Corporation With Outperform Recommendation Discover why Zacks rates FONAR Corporation as "Outperform", being the first on Wall Street to initiate coverage on the stock. Explore FONR's strategic expansion, financial health and market positioning for growth in the MRI diagnostic services space. zacks.com 2024-06-04 14:56:26 Czytaj oryginał (ang.)
Fonar Announces Fiscal 2024 Financial Results for 3rd Quarter and Nine-Month Period Total MRI scan volume at the HMCA-managed sites increased 11% to 154,790 scans for the nine-month period ended March 31, 2024 as compared to the nine-month period ended March 31, 2023. Net Income increased 25% to $12.5 million for the nine-month period ended March 31, 2024 as compared to the nine-month period ended March 31, 2023. newsfilecorp.com 2024-05-15 11:30:00 Czytaj oryginał (ang.)
FONAR: Recent Selloff Seems Unjustified As EV/EBITDA Approaches 4x The company focuses on managing diagnostic imaging centers, and it has slow and predicable revenue growth with decent margins. In my view, the Q2 FY24 results were strong as revenues inched up by 4.7% to $25.4 million while attributable net income soared by 68.4% to $3.8 million. The market capitalization of Fonar slumped by over 20% in the past month, and I think this creates a good buying opportunity here. seekingalpha.com 2024-04-10 02:27:54 Czytaj oryginał (ang.)
Fonar Announces Six Months and 2nd Quarter Financial Results for Fiscal 2024 Total MRI scan volume at the HMCA-managed sites increased 13% to 101,990 scans for the six months ending December 31, 2023 versus the corresponding period one year earlier. Cash and cash equivalents and short-term investments increased 4% to $53.2 million at December 31, 2023, versus the fiscal year ended June 30, 2023. newsfilecorp.com 2024-02-14 09:00:00 Czytaj oryginał (ang.)
Fonar Announces Financial Results for the 1st Quarter of Fiscal 2024 On September 13, 2022, the Company adopted a stock repurchase plan of up to $9 million. At September 30, 2023, the Company has purchased 146,359 shares at a cost of $2,473,215. newsfilecorp.com 2023-11-14 09:00:00 Czytaj oryginał (ang.)
Fonar Announces Distributor Agreement with Airs Medical, Leader in AI-Powered MRI Technology Melville, New York--(Newsfile Corp. - November 8, 2023) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, announces that it is now the exclusive distributor of SwiftMR™ from AIRS Medical, Inc. to FONAR customers for use on their FONAR MRIs or on any other MRI scanner they own. AIRS Medical is the leading Artificial Intelligence (AI)-powered healthcare solution provider. newsfilecorp.com 2023-11-08 13:00:00 Czytaj oryginał (ang.)
FONAR Announces Financial Results for Fiscal 2023 On August 3, 2022, FONAR founder and The Father of MRI, Raymond V. Damadian, died at 86. newsfilecorp.com 2023-09-28 11:00:00 Czytaj oryginał (ang.)
Back Into FONAR Corporation FONAR Corporation's shares have declined 8.2% since I last wrote about it, while the S&P 500 gained 10.9%. The company's recent financial results show flatlined revenue and increased costs. Despite the weak performance, FONAR has a strong capital structure and the shares are objectively cheap, making it a potentially good investment. Patience is required in my view. seekingalpha.com 2023-08-02 19:37:50 Czytaj oryginał (ang.)
7 Bargain Stocks to Snatch Up Before They Bounce Back in the Second Half Although the Covid-19 pandemic naturally sparked concerns about social unrest and economic instability, the equities market overall has been incredibly resilient, thus seemingly negating the concept of bargain stocks to buy. If you wanted to get your discount, you had to sign up during the spring doldrums of 2020. investorplace.com 2023-07-25 21:02:59 Czytaj oryginał (ang.)
FONAR: Balance Sheet Trends Point To A Firm Bottom Shortly FONAR stock is trading well below book value and remains profitable which is key. Cash, liquidity and equity all continue to grow on the balance sheet. seekingalpha.com 2022-08-31 12:31:30 Czytaj oryginał (ang.)
Adding To My Fonar Corporation Position I think the financial performance has been excellent over the past three quarters. I particularly like the renewed strength of the capital structure. At the same time, the shares are cheap by some measures, and not cheap by others. For that reason, I'm "nibbling" by buying 300 more shares. seekingalpha.com 2022-06-01 15:25:08 Czytaj oryginał (ang.)
FONAR Corporation: Finally Closing In On A Multi-Year Bottom Revenue almost hits $90 million & EBIT grows by 25% to surpass $17 million in Fonar's latest fiscal year. seekingalpha.com 2021-10-11 16:07:44 Czytaj oryginał (ang.)
FONAR Subsidiary, HMCA, Expands with Acquisition in Yonkers, New York Melville, New York--(Newsfile Corp. - March 31, 2021) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, announced today that it has acquired a Stand-Up® MRI facility in Yonkers, New York, from where its diagnostic imaging management subsidiary, Health Management Company of America (HMCA) will provide non-medical management services for Comprehensive MRI of New York, P.C.Tim Damadian, president and CEO of FONAR Corporation, said, "We're very excited about this Yonkers location. Physicians have been... newsfilecorp.com 2021-03-31 16:37:00 Czytaj oryginał (ang.)
If You Own Fonar Corporation (FONR) Stock, Should You Sell It Now? Blue Tower Asset Management's recently released its Q3 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 10.4% for the quarter, outperforming the S&P 500 Index which returned 8.9% in the same quarter. You should check out Blue Tower Asset Management's top 5 stock picks for investors to buy right now, which could be the biggest winners of this year. insidermonkey.com 2020-11-11 12:52:00 Czytaj oryginał (ang.)